MetacrineÂ Inc (MTCR) Financials

$0.58

$-0.01 (-1.29%)

As on 20-Jun-2023 15:11EDT

Market cap

$25 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	1.45	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	1.45	--
Operating Expenses	36.13	61.08	36.69	30.00	28.18	--
Operating Profit (EBIT)	-36.51	-61.08	-36.69	-30.00	-26.73	--
Other Income	--	--	--	--	--	--
Profit before Tax	-38.19	-62.21	-37.30	-28.93	-25.82	--
Provision for Tax	1.13	-1.05	-1.33	0.35	0.91	--
Profit after Tax (Net Income)	-39.32	-61.16	-35.98	-29.28	-25.82	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-38.19	-62.21	-37.30	-28.93	-25.82	-12.26

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	37.07	57.36	89.28	-78.24	-51.47	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	13.44	14.87	10.93	124.51	125.02	--
Current Liabilities	4.53	7.76	4.03	14.01	4.25	3.95
Total Liabilities	59.57	79.99	104.24	60.28	77.80	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	--	1.25	2.21	2.94	3.68	--
Current Assets	55.04	78.74	102.02	57.34	74.12	34.34
Total Assets	59.57	79.99	104.24	60.28	77.80	--
Total Debt*	13.79	13.30	9.37	11.45	2.85	--
Net Current Assets	50.51	70.98	98.00	43.33	69.87	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-47.16	-36.21	-27.75	-25.48	-10.05
Cash Flow from Investing Activities	--	43.91	-32.10	17.70	-57.22	-0.42
Cash from Financing Activities	--	27.77	77.03	9.75	64.81	22.27
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-1.12	-2.27	-4.00	--	--	--
Cash EPS ($)	--	-2.23	-3.89	--	--	--
Adjusted Book Value ($)	--	2.12	9.92	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.75	-4.02	--	--	--
Free Cash Flow per Share ($)	--	-1.75	-4.05	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-72.25	-225.82	50.74	106.23	--
ROE (%)	-94.16	-83.42	-651.60	45.15	50.17	--
ROA (%)	-57.22	-66.40	-43.73	-42.41	-33.19	--
EBIT Margin (%)	--	--	--	--	-1,780.76	--
Net Margin (%)	--	--	--	--	-1,780.76	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	-1.00	--	--
EBIT Growth (%)	37.60	-66.47	-22.28	-16.20	-109.08	--
Net Profit Growth (%)	33.91	-70.01	-22.87	-13.40	--	--
EPS Growth (%)	63.31	0.43	--	--	--	--
Book Value Growth (%)	-50.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-0.30	-1.97	--	--	--
Price / Book Value	0.40	0.32	0.79	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.67	1.19	2.46	--	--	--
Close Price ($)	0.49	0.67	7.86	--	--	--
High Price ($)	3.87	11.00	16.19	--	--	--
Low Price ($)	0.35	0.60	7.64	--	--	--
Market Cap ($ Cr)	25.48	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.34	0.23	0.10	-0.15	-0.06	--
Short term debt to equity ratio	0.03	0.01	0.01	-0.12	--	--
Current Ratio	12.15	10.15	25.34	4.09	17.44	8.69
Quick Ratio	12.15	9.91	--	--	--	--
Interest Coverage	-18.75	-50.81	-36.25	-86.47	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	0.02	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.